These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 2208108

  • 1. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG.
    Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108
    [Abstract] [Full Text] [Related]

  • 2. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 3. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

  • 4. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR, Kaufmann WK, Chaney SG.
    Carcinogenesis; 1991 Dec 01; 12(12):2253-7. PubMed ID: 1747924
    [Abstract] [Full Text] [Related]

  • 5. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 01; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 6. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK, Husain I, Sancar A, Chaney SG.
    Cancer Res; 1986 Jun 01; 46(6):2876-82. PubMed ID: 3698013
    [Abstract] [Full Text] [Related]

  • 7. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968
    [Abstract] [Full Text] [Related]

  • 8. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 9. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
    Kido Y, Khokhar AR, Siddik ZH.
    Anticancer Drugs; 1993 Apr 01; 4(2):251-8. PubMed ID: 8490203
    [Abstract] [Full Text] [Related]

  • 10. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK, Gibbons G, Wyrick SD, Chaney SG.
    Cancer Res; 1988 Sep 15; 48(18):5136-44. PubMed ID: 3409241
    [Abstract] [Full Text] [Related]

  • 11. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Anticancer Drug Des; 1994 Oct 15; 9(5):425-34. PubMed ID: 7945726
    [Abstract] [Full Text] [Related]

  • 12. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP, Khokhar AR, Brown DB, McCormack JJ, Krakoff IH.
    Cancer Res; 1985 Oct 15; 45(10):4748-53. PubMed ID: 4040806
    [Abstract] [Full Text] [Related]

  • 13. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 15; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 14. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity.
    Petersen LN, Mamenta EL, Stevnsner T, Chaney SG, Bohr VA.
    Carcinogenesis; 1996 Dec 15; 17(12):2597-602. PubMed ID: 9006094
    [Abstract] [Full Text] [Related]

  • 15. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 15; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 16. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 15; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 15; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

  • 18. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar 15; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

  • 19. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
    Hrubisko M, Kysela B, Kuliffay P.
    Neoplasma; 1989 Mar 15; 36(4):401-10. PubMed ID: 2770927
    [Abstract] [Full Text] [Related]

  • 20. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G.
    Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.